Page last updated: 2024-11-11

tilianin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tilianin: from several medicinal plants including Agastache rugosa and Dracocephalum moldavia [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Dracocephalumgenus[no description available]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]
AgastachegenusA plant genus of the family LAMIACEAE that contains tilianin, agastanol, and agastaquinone (a cytotoxic diterpenoid quinone).[MeSH]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]
Agastache rugosaspecies[no description available]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]

Cross-References

ID SourceID
PubMed CID5321954
CHEMBL ID487018
SCHEMBL ID2048512
MeSH IDM0388585

Synonyms (24)

Synonym
tilianin
CHEMBL487018
5-hydroxy-2-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
4291-60-5
4h-1-benzopyran-4-one, 7-(beta-d-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-
SCHEMBL2048512
moldavoside
5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4h-chromen-7-yl hexopyranoside #
4h-1-benzopyran-4-one, 7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-
acacetin 7-o-glucoside
NLZCOTZRUWYPTP-MIUGBVLSSA-N
moldavosid
acacetin 7-o-.beta.-d-glucopyranoside
EX-A3791
HY-N2555
CS-0022827
MS-28048
DTXSID00962790
5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4h-1-benzopyran-7-yl hexopyranoside
5-hydroxy-2-(4-methoxyphenyl)-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
acacetin-7-glucoside
tilianine
bdbm50524080
AKOS040759320

Research Excerpts

Overview

Tilianin is a flavonoid glycoside that can be found in a wide range of medicinal plants. It is acknowledged for its anti-inflammatory and antioxidant activities.

ExcerptReferenceRelevance
"Tilianin is a flavonoid glycoside that can be found in a wide range of medicinal plants and is most commonly obtained from"( Tilianin: A Potential Natural Lead Molecule for New Drug Design and Development for the Treatment of Cardiovascular Disorders.
Azad, AK; Begum, MY; Chidambaram, K; Dhiravidamani, A; Fuloria, NK; Fuloria, S; Gan, SH; Jeyabalan, S; Khattulanuar, FS; Lum, PT; Rani, NNIM; Ravi, S; Sathasivam, KV; Sekar, M; Subramaniyan, V; Thangavelu, L; Wu, YS, 2022
)
2.89
"Tilianin is a major flavonoid component of D."( Tilianin improves lipid profile and alleviates atherosclerosis in ApoE
Ding, X; Du, Y; Hong, B; Li, X; Li, Y; Wang, L; Xi, M; Xing, J; Zhang, X; Zheng, R, 2023
)
3.07
"Tilianin is a natural polyphenol, acknowledged for its anti-inflammatory and antioxidant activities."( Role of Tilianin against Acute Lung Injury in In Vitro LPS-Induced Alveolar Macrophage Cells and an In Vivo C57BL/6 Mice Model.
Fu, Z; Zhang, Y, 2020
)
1.71
"Tilianin is a polyphenol antioxidant commonly used as natural phytomedicine."( The biological and pharmacological roles of polyphenol flavonoid tilianin.
Ahn, D; Akanda, MR; Kim, IS; Park, BY; Tae, HJ; Uddin, MN, 2019
)
1.47

Effects

Tilianin has been demonstrated to exert protective effects on the heart against ischemia-reperfusion (I/R) injury. Whether it is beneficial to the mitochondria during myocardial I/R is unclear. Tilianin down-regulates TNF-alpha induced expression of vascular cell adhesion molecules in endothelial cells.

ExcerptReferenceRelevance
"Tilianin has a wide variety of pharmacological properties such as cardioprotective, neuroprotective, and anti-atherogenic activities."( Tilianin attenuates HDM-induced allergic asthma by suppressing Th2-immune responses via downregulation of IRF4 in dendritic cells.
Jang, HJ; Kang, MA; Kim, TH; Lee, HJ; Lee, K; Oh, SR; Park, SJ; Ryu, HW, 2021
)
2.79
"Tilianin has multiple biological activities including anti-inflammatory and antioxidant."( Tilianin Protects against Nonalcoholic Fatty Liver Disease in Early Obesity Mice.
Cheng, XG; Xu, SM; Xu, Y; Yang, LQ, 2023
)
3.07
"Tilianin has a wide variety of pharmacological properties such as cardioprotective, neuroprotective, and anti-atherogenic activities."( Tilianin attenuates HDM-induced allergic asthma by suppressing Th2-immune responses via downregulation of IRF4 in dendritic cells.
Jang, HJ; Kang, MA; Kim, TH; Lee, HJ; Lee, K; Oh, SR; Park, SJ; Ryu, HW, 2021
)
2.79
"Tilianin has been demonstrated to exert protective effects on the heart against ischemia-reperfusion (I/R) injury, yet whether it is beneficial to the mitochondria during myocardial I/R is unclear."( Tilianin pretreatment prevents myocardial ischemia-reperfusion injury via preservation of mitochondrial function in rat heart.
Cao, W; Guo, X; Hong, Y; Hu, P; Wang, X; Wang, Y; Yuan, Y, 2017
)
3.34
"Tilianin has been shown to down-regulate TNF-alpha induced expression of vascular cell adhesion molecules in endothelial cells. "( Inhibition of cytokine-induced IkappaB kinase activation as a mechanism contributing to the anti-atherogenic activity of tilianin in hyperlipidemic mice.
Cho, MH; Choi, JH; Hong, JJ; Kim, J; Kim, YM; Lee, HK; Mar, W; Nam, KH; Nam, KW; Oh, GT; Oh, SR, 2005
)
1.98

Actions

ExcerptReferenceRelevance
"Tilianin may inhibit OGD/R-induced H9c2 cell apoptosis mediated by mitochondrial pathway and endoplasmic reticulum stress, thus protecting cardiomyocytes."( Tilianin extracted from Xiangqinglan () inhibits apoptosis induced by mitochondrial pathway and endoplasmic reticulum stress in H9c2 cells after oxygen-glucose deprivation/reoxygenation.
Hao, Y; Junhui, C; Qiang, C; Wei, Z; Wen, J; Xiaomei, P; Yuxiang, Z, 2023
)
3.8

Treatment

Tilianin treatment significantly ameliorated liver function, inhibited hepatocyte apoptosis, and reduced lipid deposition and liver fibrosis in mice with NASH. Tilianin pretreatment was beneficial for activating the PI3K/Akt signaling pathway and inhibiting myocardial apoptosis.

ExcerptReferenceRelevance
"Tilianin treatment improved lipid profiles in C57BL/6 and dyslipidemic ApoE"( Tilianin improves lipid profile and alleviates atherosclerosis in ApoE
Ding, X; Du, Y; Hong, B; Li, X; Li, Y; Wang, L; Xi, M; Xing, J; Zhang, X; Zheng, R, 2023
)
3.8
"Tilianin treatment significantly ameliorated liver function, inhibited hepatocyte apoptosis, and reduced lipid deposition and liver fibrosis in mice with NASH."( Tilianin alleviates lipid deposition and fibrosis in mice with nonalcoholic steatohepatitis by activating the PPARα/Nnat axis.
Ke, F; Li, C; Wu, X; Zheng, J, 2023
)
3.07
"Tilianin was treated in splenocytes cultured in Th0 condition and HDM-stimulated bone marrow-derived dendritic cells (BMDCs), and their mRNA expression and cytokines production were determined by quantitative real-time PCR and ELISA. "( Tilianin attenuates HDM-induced allergic asthma by suppressing Th2-immune responses via downregulation of IRF4 in dendritic cells.
Jang, HJ; Kang, MA; Kim, TH; Lee, HJ; Lee, K; Oh, SR; Park, SJ; Ryu, HW, 2021
)
3.51
"Tilianin pretreatment was beneficial for activating the PI3K/Akt signaling pathway and inhibiting myocardial apoptosis."( Cardioprotection of tilianin ameliorates myocardial ischemia-reperfusion injury: Role of the apoptotic signaling pathway.
He, C; Jiang, W; Li, J; Xing, J; Zeng, C; Zheng, R, 2018
)
1.53

Bioavailability

ExcerptReferenceRelevance
", enterohepatic, enteric and local recycling) plays a central role in governing the disposition of phenolics such as flavonoids, resulting in low systemic bioavailability but higher gut bioavailability and longer than expected apparent half-life."( Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids.
Dai, P; Hu, M; Li, Q; Liu, Z; Lu, L; Luo, F; Wang, L; Wang, X; Wang, Y; Zhu, L, 2015
)
0.42
" Thus, to improve the oral bioavailability of tilianin, composite phospholipid liposomes were adopted in this work as a novel nanoformulation."( Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
He, C; Huang, W; Jiang, W; Tan, M; Xing, J; Yang, X; Zeng, C, 2016
)
0.96
" The present study aimed to formulate lipid-polymer hybrid nanoparticles (LPHNs) as carriers for the sustained release and oral bioavailability enhancement of TIL in vitro and in vivo."( Improved oral delivery of tilianin through lipid-polymer hybrid nanoparticles to enhance bioavailability.
Du, Y; Lan, W; Xing, J; Yang, X; Zeng, C; Zheng, R, 2019
)
0.81
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TyrosinaseHomo sapiens (human)IC50 (µMol)50.00000.02304.459310.0000AID1594853
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (11)

Processvia Protein(s)Taxonomy
melanin biosynthetic process from tyrosineTyrosinaseHomo sapiens (human)
eye pigment biosynthetic processTyrosinaseHomo sapiens (human)
visual perceptionTyrosinaseHomo sapiens (human)
cell population proliferationTyrosinaseHomo sapiens (human)
response to UVTyrosinaseHomo sapiens (human)
response to blue lightTyrosinaseHomo sapiens (human)
response to vitamin DTyrosinaseHomo sapiens (human)
melanin biosynthetic processTyrosinaseHomo sapiens (human)
thymus developmentTyrosinaseHomo sapiens (human)
response to cAMPTyrosinaseHomo sapiens (human)
pigmentationTyrosinaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
tyrosinase activityTyrosinaseHomo sapiens (human)
copper ion bindingTyrosinaseHomo sapiens (human)
protein bindingTyrosinaseHomo sapiens (human)
identical protein bindingTyrosinaseHomo sapiens (human)
protein homodimerization activityTyrosinaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
cytoplasmTyrosinaseHomo sapiens (human)
lysosomeTyrosinaseHomo sapiens (human)
Golgi-associated vesicleTyrosinaseHomo sapiens (human)
melanosome membraneTyrosinaseHomo sapiens (human)
melanosomeTyrosinaseHomo sapiens (human)
intracellular membrane-bounded organelleTyrosinaseHomo sapiens (human)
perinuclear region of cytoplasmTyrosinaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID528043Antioxidant activity of the compound assessed as DPPH radical scavenging activity after 30 mins2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells.
AID1775659Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay2021Journal of natural products, 03-26, Volume: 84, Issue:3
Sesquiterpenoids from
AID338974Inhibition of cow milk xanthine oxidase at 50 ug/mL
AID528044Antioxidant activity assessed as ferrous ion chelating activity2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells.
AID1775658Inhibition of LPS induced NO production in mouse RAW264.7 cells measured after 24 hrs by Griess reagent based assay2021Journal of natural products, 03-26, Volume: 84, Issue:3
Sesquiterpenoids from
AID1233227Cytotoxicity against mouse B16-4A5 cells assessed as cell viability at 1 uM after 70 hrs by WST-8 assay relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1162204Cytotoxicity against mouse RAW264.7 cells at 0.01 to 100 uM after 24 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
New guaiane sesquiterpenes from Artemisia rupestris and their inhibitory effects on nitric oxide production.
AID528045Antioxidant activity assessed as ABTS radical scavenging activity2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells.
AID1233223Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 10 uM after 72 hrs by microplate reader analysis relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1594853Inhibition of tyrosinase (unknown origin)2019Journal of natural products, 06-28, Volume: 82, Issue:6
Isolation of Sesquiterpene-Amino Acid Conjugates, Onopornoids A-D, and a Flavonoid Glucoside from Onopordum alexandrinum.
AID1233226Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells after 72 hrs by microplate reader analysis2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1162203Inhibition of NO production in LPS-stimulated mouse RAW264.7 cells pre-incubated for 2 hrs before LPS stimulation for 24 hrs by Griess assay method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
New guaiane sesquiterpenes from Artemisia rupestris and their inhibitory effects on nitric oxide production.
AID1594855Antimicrobial activity against bacteria2019Journal of natural products, 06-28, Volume: 82, Issue:6
Isolation of Sesquiterpene-Amino Acid Conjugates, Onopornoids A-D, and a Flavonoid Glucoside from Onopordum alexandrinum.
AID528046Cytoprotective activity against doxorubicin-induced cytotoxicity in rat H9c2 cells assessed as cell viability after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells.
AID1233232Inhibition of mushroom tyrosinase using L-DOPA as substrate assessed as dopaquinone production at 10 uM after 5 mins by microplate reader analysis relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1233221Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 1 uM after 72 hrs by microplate reader analysis relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1233229Cytotoxicity against mouse B16-4A5 cells assessed as cell viability at 10 uM after 70 hrs by WST-8 assay relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1233228Cytotoxicity against mouse B16-4A5 cells assessed as cell viability at 3 uM after 70 hrs by WST-8 assay relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1233222Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 3 uM after 72 hrs by microplate reader analysis relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1594854Antimicrobial activity against Leishmania2019Journal of natural products, 06-28, Volume: 82, Issue:6
Isolation of Sesquiterpene-Amino Acid Conjugates, Onopornoids A-D, and a Flavonoid Glucoside from Onopordum alexandrinum.
AID1617647Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as decrease in PGE2 production preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA
AID1233233Inhibition of mushroom tyrosinase using L-DOPA as substrate assessed as dopaquinone production at 100 uM after 5 mins by microplate reader analysis relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1233244Inhibition of plasmin (unknown origin) at 100 uM after 18 hrs by arianor mahogany dye-based fibrin plate assay relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (1.92)18.2507
2000's6 (11.54)29.6817
2010's32 (61.54)24.3611
2020's13 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.32 (24.57)
Research Supply Index3.99 (2.92)
Research Growth Index5.64 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.77%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other51 (96.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]